BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 15235898)

  • 1. Hepatocellular carcinoma associated with autoimmune hepatitis.
    Nishiyama R; Kanai T; Abe J; Hara R; Watahiki Y; Sakaguchi T; Nakamura S
    J Hepatobiliary Pancreat Surg; 2004; 11(3):215-9. PubMed ID: 15235898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatic and extrahepatic malignancies in autoimmune hepatitis. A long-term follow-up in 473 Swedish patients.
    Werner M; Almer S; Prytz H; Lindgren S; Wallerstedt S; Björnsson E; Bergquist A; Sandberg-Gertzén H; Hultcrantz R; Sangfelt P; Weiland O; Danielsson A
    J Hepatol; 2009 Feb; 50(2):388-93. PubMed ID: 19070390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Favorable outcomes of autoimmune hepatitis in a community clinic setting.
    Seo S; Toutounjian R; Conrad A; Blatt L; Tong MJ
    J Gastroenterol Hepatol; 2008 Sep; 23(9):1410-4. PubMed ID: 18373564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multifocal hepatocellular carcinoma and precancerous lesions in a patient with autoimmune hepatitis-related cirrhosis.
    Ward SC; Deniz K; Roayaie S; Qin L
    Semin Liver Dis; 2008 Feb; 28(1):123-7. PubMed ID: 18293282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictive factors for hepatocellular carcinoma in type 1 autoimmune hepatitis.
    Montano-Loza AJ; Carpenter HA; Czaja AJ
    Am J Gastroenterol; 2008 Aug; 103(8):1944-51. PubMed ID: 18564111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The pathogenesis of hepatocellular carcinoma is multifactorial event. Novel immunological treatment in prospect.
    Marotta F; Vangieri B; Cecere A; Gattoni A
    Clin Ter; 2004 May; 155(5):187-99. PubMed ID: 15344567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of risk factors in the development of hepatocellular carcinoma in autoimmune hepatitis: Implications for follow-up and screening.
    Yeoman AD; Al-Chalabi T; Karani JB; Quaglia A; Devlin J; Mieli-Vergani G; Bomford A; O'Grady JG; Harrison PM; Heneghan MA
    Hepatology; 2008 Sep; 48(3):863-70. PubMed ID: 18752332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and pathological factors associated with the development of hepatocellular carcinoma in patients with hepatitis virus-related cirrhosis: a long-term follow-up study.
    Rodríguez-Díaz JL; Rosas-Camargo V; Vega-Vega O; Morales-Espinosa D; Mendez-Reguera A; Martínez-Tlahuel JL; Gamboa-Domínguez A; Arrieta O
    Clin Oncol (R Coll Radiol); 2007 Apr; 19(3):197-203. PubMed ID: 17359907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatic steatosis is associated with increased frequency of hepatocellular carcinoma in patients with hepatitis C-related cirrhosis.
    Pekow JR; Bhan AK; Zheng H; Chung RT
    Cancer; 2007 Jun; 109(12):2490-6. PubMed ID: 17487861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatocellular carcinoma arising from autoimmune hepatitis: report of a case.
    Okino H; Satoh T; Watanabe J; Masumoto A; Takeda S
    Surg Today; 2007; 37(8):716-8. PubMed ID: 17643223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. De novo autoimmune hepatitis following liver transplantation: a case report.
    Di Cocco P; Barletta A; Clemente K; D'Angelo M; Greco S; Mazzotta C; Orlando G; Rizza V; Famulari A; Grimaldi A; Pisani F
    Transplant Proc; 2008; 40(6):2073-4. PubMed ID: 18675134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic factors after liver resection for hepatocellular carcinoma with hepatitis B virus-related cirrhosis: surgeon's role in survival.
    Zhang XF; Meng B; Qi X; Yu L; Liu C; Liu XM; Wang B; Pan CE; Lv Y
    Eur J Surg Oncol; 2009 Jun; 35(6):622-8. PubMed ID: 18835514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survival outcomes in liver transplantation for hepatocellular carcinoma, comparing impact of hepatitis C versus other etiology of cirrhosis.
    Bozorgzadeh A; Orloff M; Abt P; Tsoulfas G; Younan D; Kashyap R; Jain A; Mantry P; Maliakkal B; Khorana A; Schwartz S
    Liver Transpl; 2007 Jun; 13(6):807-13. PubMed ID: 17539001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors analysis for hepatocellular carcinoma in patients with and without cirrhosis: a case-control study of 213 hepatocellular carcinoma patients from India.
    Kumar M; Kumar R; Hissar SS; Saraswat MK; Sharma BC; Sakhuja P; Sarin SK
    J Gastroenterol Hepatol; 2007 Jul; 22(7):1104-11. PubMed ID: 17559381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence and predictors of hepatocellular carcinoma in patients with autoimmune hepatitis.
    Colapietro F; Maisonneuve P; Lytvyak E; Beuers U; Verdonk RC; van der Meer AJ; van Hoek B; Kuiken SD; Brouwer JT; Muratori P; Aghemo A; Carella F; van den Berg AP; Zachou K; Dalekos GN; Di Zeo-Sánchez DE; Robles M; Andrade RJ; Montano-Loza AJ; van den Brand FF; Slooter CD; Macedo G; Liberal R; de Boer YS; Lleo A; ;
    J Hepatol; 2024 Jan; 80(1):53-61. PubMed ID: 37802188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hepatocellular carcinoma and cholangiocarcinoma--different prognosis, pathogenesis and therapy].
    Tischoff I; Tannapfel A
    Zentralbl Chir; 2007 Aug; 132(4):300-5. PubMed ID: 17724632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors for hepatocellular carcinoma in Japanese patients with autoimmune hepatitis type 1.
    Hino-Arinaga T; Ide T; Kuromatsu R; Miyajima I; Ogata K; Kuwahara R; Hisamochi A; Torimura T; Sata M;
    J Gastroenterol; 2012 May; 47(5):569-76. PubMed ID: 22187167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ursodiol use is possibly associated with lower incidence of hepatocellular carcinoma in hepatitis C virus-associated liver cirrhosis.
    Tarao K; Fujiyama S; Ohkawa S; Miyakawa K; Tamai S; Hirokawa S; Masaki T; Tanaka K
    Cancer Epidemiol Biomarkers Prev; 2005 Jan; 14(1):164-9. PubMed ID: 15668491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors predicting relapse and poor outcome in type I autoimmune hepatitis: role of cirrhosis development, patterns of transaminases during remission and plasma cell activity in the liver biopsy.
    Verma S; Gunuwan B; Mendler M; Govindrajan S; Redeker A
    Am J Gastroenterol; 2004 Aug; 99(8):1510-6. PubMed ID: 15307869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hepatocellular carcinoma complicating autoimmune hepatitis].
    Masaki N; Hayashi S
    Nihon Rinsho; 2001 Oct; 59 Suppl 6():455-64. PubMed ID: 11761993
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.